Skip to main content
logo
Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
101.50
+1.90 (1.91%)
At close: May 29, 2026, 4:00 PM EDT
102.00
+0.50 (0.49%)
After-hours: May 29, 2026, 7:55 PM EDT

Mirum Pharmaceuticals Revenue

Mirum Pharmaceuticals had revenue of $159.88M in the quarter ending March 31, 2026, with 43.28% growth. This brings the company's revenue in the last twelve months to $569.61M, up 50.19% year-over-year. In the year 2025, Mirum Pharmaceuticals had annual revenue of $521.31M with 54.74% growth.

Revenue (ttm)
$569.61M
Revenue Growth
+50.19%
P/S Ratio
10.87
Revenue / Employee
$1,362,701
Employees
418
Market Cap
6.19B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025521.31M184.42M54.74%
Dec 31, 2024336.89M150.51M80.76%
Dec 31, 2023186.37M109.31M141.85%
Dec 31, 202277.06M57.92M302.66%
Dec 31, 202119.14M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
PTC Therapeutics827.11M
Rhythm Pharmaceuticals217.17M
Protagonist Therapeutics74.06M
Kymera Therapeutics51.48M
Centessa Pharmaceuticals15.00M
Revenue Rankings

MIRM News

More News